A 58-year-old man from Mumbai presents with acute onset swelling, pain, and warmth in the right lower limb over the past 24 hours. He had undergone total knee replacement 10 days ago. On examination, the right calf is swollen (3 cm difference in circumference compared to left), tender, and warm. Homan's sign is positive. D-dimer is elevated at 1.2 μg/mL (normal <0.5). Compression ultrasound shows a hypoechoic, non-compressible thrombus in the popliteal vein extending into the distal femoral vein. What is the most appropriate initial management?

Explanation

## Clinical Diagnosis: Proximal DVT Post-Operatively This patient has **acute proximal DVT** (femoral and popliteal veins involved) in the immediate post-operative period following orthopedic surgery—a major risk factor. The clinical presentation (swelling, pain, warmth, positive Homan's sign) and ultrasound confirmation establish the diagnosis. ## DVT Risk Stratification & Management Algorithm ```mermaid flowchart TD A[Confirmed DVT on ultrasound]:::outcome --> B{Proximal or distal?}:::decision B -->|Distal only| C{Symptomatic?}:::decision B -->|Proximal| D[Anticoagulation indicated]:::action C -->|Asymptomatic| E[Surveillance ultrasound]:::action C -->|Symptomatic| D D --> F{Contraindication to anticoagulation?}:::decision F -->|No| G[UFH or LMWH + warfarin/DOAC]:::action F -->|Yes| H[IVC filter consideration]:::action G --> I[Leg elevation, compression, analgesia]:::action I --> J[Monitor for PE, extension, recurrence]:::outcome K[Thrombolysis only if:<br/>Massive iliofemoral thrombosis<br/>Phlegmasia cerulea dolens<br/>Upper limb DVT<br/>Acute limb ischemia]:::urgent ``` ## First-Line Anticoagulation for Acute DVT **Key Point:** Anticoagulation is the **standard of care** for proximal DVT. Immediate anticoagulation prevents thrombus propagation and reduces PE risk by ~80%. | Agent | Mechanism | Onset | Use in DVT | |-------|-----------|-------|------------| | **UFH** | Direct thrombin inhibitor | Immediate (IV) | First-line; allows rapid reversal; preferred if renal failure or urgent surgery anticipated | | **LMWH** | Factor Xa inhibitor | 3–4 hours (SC) | Alternative; predictable pharmacokinetics; SC dosing | | **Warfarin** | Vitamin K antagonist | 3–5 days | Bridge therapy; long-term anticoagulation | | **DOAC** | Factor Xa or IIa inhibitor | 1–2 hours (apixaban, rivaroxaban) | Alternative to warfarin; not for acute phase | **High-Yield:** UFH is preferred in the **acute post-operative setting** because: - Rapid IV onset (immediate anticoagulation) - Short half-life (~60–90 min) → reversible if bleeding occurs - Allows urgent re-operation if needed - Can transition to warfarin or DOAC after 5–7 days ## Supportive Measures **Clinical Pearl:** Early mobilization, leg elevation, and compression stockings reduce pain and edema but do NOT replace anticoagulation. 1. **Leg elevation** above heart level → reduces edema 2. **Compression therapy** (Class II–III stockings) → improves venous return, reduces pain 3. **Analgesia** (NSAIDs, opioids if needed) 4. **Early mobilization** once anticoagulation established ## Why Other Options Are Incorrect **Option A (Immediate thrombolysis):** Thrombolysis is **NOT standard** for acute DVT and carries significant bleeding risk. Reserved only for: - **Massive iliofemoral thrombosis** with limb-threatening ischemia (phlegmasia cerulea dolens) - **Acute upper limb DVT** (Paget–Schroetter syndrome) - **Acute limb ischemia** from thrombosis - This patient has uncomplicated proximal DVT—anticoagulation alone is appropriate. **Option C (Observation with conditional anticoagulation):** **Proximal DVT always requires anticoagulation**, regardless of whether thrombus extends further. Delaying anticoagulation increases PE risk and allows propagation. This approach is only acceptable for **asymptomatic distal DVT**. **Option D (Mechanical thrombectomy + IVC filter):** - **Thrombectomy** is reserved for massive iliofemoral thrombosis with limb ischemia or phlegmasia—not for uncomplicated proximal DVT. - **IVC filter** is indicated only if anticoagulation is **contraindicated** (active bleeding, recent intracranial hemorrhage, etc.). This patient has no such contraindication. ## Duration of Anticoagulation **Post-operative DVT is provoked** (surgery is a transient risk factor). Standard duration: - **3 months** of anticoagulation (warfarin INR 2–3 or DOAC) - Then reassess need for extended therapy - Recurrent DVT or unprovoked DVT → consider extended or indefinite anticoagulation ## Summary Anticoagulation with UFH (or LMWH) followed by warfarin is the **gold-standard first-line treatment** for acute proximal DVT. Supportive measures (elevation, compression, analgesia) complement anticoagulation but do not replace it.